Trial Profile
Evaluation of Dotarem Safety
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Gadoterate-meglumine (Primary)
- Indications CNS disorders; Vascular disorders
- Focus Adverse reactions
- Sponsors Guerbet
- 14 Feb 2017 New trial record